Pepdox
Studies
Peptides
Calculator
Real-World Evidence Assessment of the Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. | Pepdox
Home
/
Search
/
PMID 39080859
Real-World Evidence Assessment of the Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.
Journal of diabetes science and technology
2024
PMID: 39080859
View on PubMed
DOI: 10.1177/19322968241268050
Semaglutide
Authors
Klonoff, David C; Hui, Gavin; Gombar, Saurabh
Keywords
GLP-1RA
blindness
optic neuritis
real-world evidence
semaglutide